Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Risk Management in Cream Manufacturing Processes – V 2.0

Posted on By

Creams: SOP for Risk Management in Cream Manufacturing Processes – V 2.0

Standard Operating Procedure for Risk Management in Cream Manufacturing Processes

Department Creams
SOP No. SOP/CRM/186/2025
Supersedes SOP/CRM/186/2022
Page No. Page 1 of 6
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to establish a structured process for identifying, assessing, and mitigating risks in the cream manufacturing process. The goal is to ensure that potential risks to product quality, safety, and regulatory compliance are managed effectively throughout production.

2. Scope

This SOP applies to all stages of the cream manufacturing process, including raw material handling, formulation, processing, packaging, and storage. It covers the identification, assessment, and management of risks that could impact product quality, safety, or compliance.

3. Responsibilities

  • Production Team: Responsible for identifying potential risks during the manufacturing process and implementing risk control measures as part of the production workflow.
  • Quality Control (QC) Team: Responsible for identifying risks related to product quality during testing and for helping to develop risk mitigation strategies.
  • Quality Assurance (QA) Team: Responsible for overseeing the risk management process, conducting risk assessments, and ensuring that identified risks are appropriately mitigated and documented.
  • Regulatory Affairs Team: Responsible for ensuring that risk
management procedures comply with regulatory requirements and that risks impacting compliance are addressed in accordance with external standards.

4. Accountability

The QA Manager is accountable for overseeing the risk management process, ensuring that risks are assessed and mitigated appropriately. The Production Manager is responsible for identifying risks within production and ensuring that effective risk control measures are in place. Department heads are responsible for ensuring compliance within their respective areas.

5. Procedure

5.1 Risk Identification

  1. Risk identification should begin during the planning phase of production and continue throughout the manufacturing process.
  2. Risks may arise from various sources, including:
    • Raw materials (e.g., contamination, variability)
    • Process variables (e.g., temperature, mixing time)
    • Equipment malfunction or failure
    • Human error or insufficient training
    • Regulatory changes
    • Packaging and storage conditions
  3. Production and QC teams should collaborate to identify risks and record them in the Risk Management Log (Annexure-1).

5.2 Risk Assessment

  1. Once risks have been identified, a formal risk assessment must be conducted by the QA team, in collaboration with the production and QC teams.
  2. Each risk should be assessed based on two factors:
    • The likelihood of the risk occurring
    • The potential impact on product quality, safety, or compliance if the risk occurs
  3. Risks are rated on a scale (e.g., low, medium, high) for both likelihood and impact, creating a risk matrix to prioritize risks.
  4. The results of the risk assessment should be documented in the Risk Assessment Report (Annexure-2).

5.3 Risk Mitigation

  1. For each identified and assessed risk, a risk mitigation plan should be developed. The plan should outline specific actions to reduce or eliminate the risk.
  2. Mitigation strategies may include:
    • Modifying processes or equipment
    • Implementing additional quality checks or controls
    • Training staff to minimize human error
    • Developing contingency plans for equipment failures or raw material shortages
    • Updating procedures to ensure compliance with regulatory changes
  3. Mitigation measures should be implemented immediately and reviewed periodically for effectiveness. Responsible individuals or teams must be assigned to carry out each action.

5.4 Monitoring and Review

  1. After implementing risk mitigation strategies, the risk must be monitored to ensure that the mitigation actions are effective and that the risk is under control.
  2. Follow-up audits or reviews should be conducted to verify the success of the mitigation actions.
  3. If new risks arise or if existing risks change, the risk assessment should be updated and new mitigation actions should be implemented as necessary.
  4. All monitoring and review activities must be documented in the Risk Management Log (Annexure-1) and Risk Assessment Report (Annexure-2).

5.5 Communication and Training

  1. Effective communication is essential to ensure that all relevant departments are aware of identified risks and the actions required to mitigate them.
  2. All staff involved in the cream manufacturing process should be trained on the risk management procedures, including how to identify potential risks and what actions to take when risks are identified.
  3. Regular training sessions should be conducted to reinforce the importance of risk management and ensure staff is aware of any new risks or changes to existing risks.

5.6 Documentation and Record-Keeping

  1. All risk management activities, including risk identification, assessment, mitigation, and monitoring, must be thoroughly documented.
  2. Risk management documents include:
    • Risk Management Log (Annexure-1)
    • Risk Assessment Report (Annexure-2)
    • Mitigation Action Plan
    • Training records
  3. All records must be retained for a minimum of two years or as required by regulatory guidelines.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QA: Quality Assurance
  • QC: Quality Control
  • PPE: Personal Protective Equipment
  • SOP: Standard Operating Procedure
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Annexure-1: Risk Management Log
  2. Annexure-2: Risk Assessment Report

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Risk Management in Pharmaceutical Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Risk Management Log

Risk Description Risk Rating (Likelihood/Impact) Mitigation Actions Responsible Person Status
Risk of contamination due to incorrect raw material storage High/High Improve raw material handling and storage protocols Production Manager In Progress

Annexure-2: Risk Assessment Report

Risk Description Impact Likelihood Risk Rating Recommended Actions
Equipment malfunction during mixing High Medium Medium Schedule regular maintenance and calibration

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Preparing Equipment for CIP and SIP Processes - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Biosimilars: SOP for Disposal of Culture Waste – V 2.0
Next Post: Elixir Department: SOP for Use of Transfer Pumps in Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version